Faringopront (Tablets) Instructions for Use
Marketing Authorization Holder
Avva Rus, JSC (Russia)
ATC Code
R02AA01 (Ambazone)
Active Substance
Ambazone (Rec.INN registered by WHO)
Dosage Forms
| Faringopront | Lozenges 10 mg: 10 or 20 pcs. | |
| Lozenges (cinnamon flavor) 10 mg: 10 or 20 pcs. | ||
| Lozenges with lemon flavor 10 mg: 10 or 20 pcs. |
Dosage Form, Packaging, and Composition
Lozenges from light brown to brown in color, round, biconvex, with a bevel, with inclusions from almost white to dark brown.
| 1 tab. | |
| Ambazone monohydrate | 10 mg |
Excipients: lactitol – 400 mg, lactose monohydrate – 150 mg, cocoa powder – 98 mg, povidone K-29/32 – 50 mg, hypromellose – 42 mg, stearic acid – 10 mg, sorbitol – to obtain a tablet weighing 1400 mg.
10 pcs. – contour cell packaging (1) – cardboard packs.
10 pcs. – contour cell packaging (2) – cardboard packs.
Lozenges with cinnamon flavor from light brown to brown in color, round, biconvex, with a bevel, with inclusions from almost white to dark brown.
| 1 tab. | |
| Ambazone monohydrate | 10 mg |
Excipients: lactitol – 400 mg, lactose monohydrate – 150 mg, cocoa powder – 98 mg, povidone K-29/32 – 50 mg, hypromellose – 42 mg, stearic acid – 10 mg, cinnamon flavor – 2 mg, sorbitol – to obtain a tablet weighing 1400 mg.
10 pcs. – contour cell packaging (1) – cardboard packs.
10 pcs. – contour cell packaging (2) – cardboard packs.
Lozenges with lemon flavor from light brown to brown in color, round, biconvex, with a bevel, with inclusions from almost white to dark brown.
| 1 tab. | |
| Ambazone monohydrate | 10 mg |
Excipients: lactitol – 400 mg, lactose monohydrate – 150 mg, cocoa powder – 98 mg, povidone K-29/32 – 50 mg, hypromellose – 42 mg, stearic acid – 10 mg, lemon flavor – 2 mg, sorbitol – to obtain a tablet weighing 1400 mg.
10 pcs. – contour cell packaging (1) – cardboard packs.
10 pcs. – contour cell packaging (2) – cardboard packs.
Clinical-Pharmacological Group
Topical antiseptic for use in ENT practice and dentistry
Pharmacotherapeutic Group
Drugs for the treatment of throat diseases; antiseptic agents
Pharmacological Action
An antiseptic agent for topical use in ENT practice and dentistry.
It has a bacteriostatic effect.
It is active against Streptococcus haemolyticus, Streptococcus viridans, and Pneumococcus.
Indications
Prevention and treatment of acute infectious and inflammatory diseases of the oral cavity and larynx (tonsillitis, stomatitis, gingivitis).
Prevention of infectious and inflammatory diseases after tooth extraction.
ICD codes
| ICD-10 code | Indication |
| J03 | Acute tonsillitis |
| J35.0 | Chronic tonsillitis |
| K05 | Gingivitis and periodontal diseases |
| K12 | Stomatitis and related lesions |
| Z29.8 | Other specified prophylactic measures |
| ICD-11 code | Indication |
| CA03.Z | Acute tonsillitis, unspecified |
| CA0F.Y | Other specified chronic diseases of the palatine tonsils and adenoids |
| DA01.Z | Diseases of the oral mucosa, unspecified |
| DA0B.Z | Gingival diseases, unspecified |
| DA0C.Z | Periodontal diseases, unspecified |
| DA0Z | Diseases or disorders of the orofacial complex, unspecified |
| QC05.Z | Prophylactic measures, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Administer the tablets by slow dissolution in the mouth.
For adults, the standard dosage is 3 to 5 lozenges per day, each containing 10 mg of ambazone.
Divide the total daily dose into individual doses taken at regular intervals.
The typical treatment duration is 3 to 4 days.
For children aged 3 to 7 years, the dosage is 3 lozenges per day.
Ensure the child can safely dissolve the lozenge to prevent a choking hazard.
Do not exceed the recommended daily dose.
After taking a lozenge, refrain from eating or drinking for 3 hours to maximize the local therapeutic effect.
If symptoms persist beyond 4 days, discontinue use and consult a physician.
Adverse Reactions
Possible allergic reactions.
Contraindications
Hypersensitivity to ambazone.
Use in Pregnancy and Lactation
During pregnancy and breastfeeding, it is used in cases where the expected benefit of therapy for the mother outweighs the possible risk to the fetus or infant.
Use in Hepatic Impairment
No special precautions.
Use in Renal Impairment
No special precautions.
Pediatric Use
Used in children over 3 years of age.
Geriatric Use
No special precautions.
Special Precautions
After taking ambazone, it is recommended to refrain from eating and drinking for 3 hours.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer